MedTrace Logo

Evaluation of In-lab Benefit for Speech-in-noise Intelligibility With Device for Adults With Mild to Moderate Hearing Loss

NCT07074769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-09-05

No results posted yet for this study

Summary

Evaluation of in-lab benefit for speech-in-noise intelligibility with the device for adults with mild to moderate hearing loss.

Conditions

Interventions

DEVICE

Evaluation of speech-in-noise intelligibility and listening effort

The speech in noise testing will be performed in lab settings; the listening effort evaluated trough a standardized questionnaire

Sponsors & Collaborators

  • University of Western Ontario, Canada

    collaborator OTHER

  • Luxottica Group S.p.A.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-23
Primary Completion
2025-08-28
Completion
2025-08-28

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07074769 on ClinicalTrials.gov